| Literature DB >> 31410323 |
Michael Esang1, Sabina Goldstein2, Ravina Dhami2.
Abstract
Although a standard psychiatric evaluation includes a physical examination, there are no guidelines on the components of a comprehensive physical examination during psychiatric patient encounters. The mental status examination is frequently considered the psychiatric physical examination equivalent. We report a 59-year-old male inpatient on a medical unit who had hyperthermia, an altered mental status, muscle rigidity, and elevated white blood cell count and creatine phosphokinase level. He had been taking risperidone 1 mg orally every 12 hours for two months. His primary treatment team suspected Neuroleptic Malignant Syndrome (NMS), but the consulting psychiatrist detected equivocal findings on physical examination and recommended a broader differential diagnosis. Further investigations revealed the possibility of an infection. The patient was positive for immunoglobulin G (IgG) antibodies to HSV-1 and HSV-2 on cerebrospinal fluid analysis. He was then treated for Herpes Simplex Encephalitis (HSE) with an oral course of acyclovir. Although NMS was low in the diagnostic ranking, given the possibility of an atypical form and the lethality of this condition if untreated, he also received intravenous lorazepam at 2 mg every six hours. He experienced full resolution of his symptoms and was stable for discharge. HSE and NMS are two examples of neuropsychiatric disorders with similar presenting symptoms. HSE frequently presents with predominantly psychiatric symptoms, such as paranoia, hallucinations, and an altered mental status. Consequently, it is typically not the first diagnosis that comes to mind, especially when these symptoms occur in a patient already being treated by a psychiatrist. Confirmation bias is the tendency for an individual to focus on the information that aligns with one's preconceptions and to ignore information that defies it. Due to this bias, physicians may attribute all symptoms of a known psychiatric patient to a psychiatric cause, instead of considering an organic etiology. In this case, the evaluation by the psychiatrist was crucial in guiding the treatment team to a diagnosis of HSE. This is important since a delayed treatment of HSE can be fatal. The literature review reveals a general consensus among psychiatrists on the value of physical examinations in patient care. In spite of this, the majority of psychiatrists seldom perform physical examinations due to concerns over skill atrophy and the potential that doing so may change the therapeutic dynamic. Others have disputed these claims and have argued that physical examinations in a psychiatric setting will not only strengthen the perception of a psychiatrist as a physician by the patient but will also allow for better care of psychiatrically ill patients. Psychiatrists should remember that they are oftentimes the sole healthcare provider for psychiatric patients and that these patients may not have the access to primary care physicians and may lack the ability to explain their symptoms or advocate for themselves. Therefore, incorporating an emphasis on performing physical examinations during psychiatry residency training and in continuing medical education programs for psychiatrists is essential.Entities:
Keywords: herpes simplex encephalitis; neuroleptic malignant syndrome; neuropsychiatric symptoms; physical examination; psychiatry
Year: 2019 PMID: 31410323 PMCID: PMC6684120 DOI: 10.7759/cureus.4840
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Non-contrast CT scan of the head showing enlarged left lateral ventricle and encephalomalacia in the left middle cerebral artery territory (black arrows).
Figure 2T1-weighted MRI scan of the brain (without contrast) also showing an enlarged left lateral ventricle and encephalomalacia in the left middle cerebral artery territory (black arrows).
Figure 3EEG from a routine portable encephalography (using 10-20 recording) showing superimposed spike activity (black arrow) over background slowing.
EEG: electroencephalogram
Reported laboratory test values for the presented case.
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; WBC: white blood cell; CPK: creatine phosphokinase; CSF: cerebrospinal fluid; RBC: red blood cell
| Test | Result | Normal Range |
| CRP | 0.8 mg/dL | 0.0-0.3 mg/dL |
| ESR | 81 mm/Hour | 0-30 mm/Hour |
| WBC | 25,050/mm3 | 4.5-11.0/mm3 |
| Band Neutrophils | 9% | 0-5.0% |
| CPK | 11,627 U/L | 38-244 U/L |
| Procalcitonin | 4.81 ng/mL | <0.1 ng/mL |
| CSF Protein | 64 mg/dL | 15-45 mg/dL |
| CSF Glucose | 81 mg/dL | 40-70 mg/dL |
| CSF RBCs | 208/mm3 | 0/mm3 |
Herpes simplex encephalitis.
EEG: electroencephalogram; HSE: herpes simplex encephalitis
| The most common cause of non-endemic, acute fatal encephalitis in the Western world. |
| High level of clinical suspicion is necessary. |
| First central nervous system viral infection to be successfully treated with antiviral therapy. |
| One of the first to have routine cerebrospinal fluid polymerase-chain reaction diagnosis with high specificity and sensitivity. |
| Seen in neonates and adults. |
| Abrupt onset with frontotemporal features. |
| Initiation of treatment on clinical suspicion is required. |
| A combination of magnetic resonance imaging, EEG, and cerebrospinal fluid tests is usually diagnostic. |
| High mortality and morbidity in untreated patients. |
| Milder symptoms in atypical HSE. |
Neuroleptic malignant syndrome diagnostic criteria - expert panel consensus.
* The mean priority score indexes each criterion according to its relative importance in making a diagnosis of neuroleptic malignant syndrome (NMS) according to an expert panel.
| Diagnostic Criteria | Priority Score * |
| Exposure to dopamine antagonist, or dopamine agonist with withdrawal, within past 72 hours | 20 |
| Hyperthermia (> 100.4 F or > 38.0 C on at least 2 occasions, measured orally) | 18 |
| Rigidity | 17 |
| Mental status alteration (reduced or fluctuating level of consciousness) | 13 |
| Creatine kinase elevation (at least 4 times the upper limit of normal) | 10 |
| Sympathetic nervous system lability, defined as at least 2 of the following: Blood pressure elevation (systolic or diastolic > 25 percent above baseline) Blood pressure fluctuation (> 20mmHg diastolic change or > 25mmHg systolic change within 24 hours) Diaphoresis Urinary incontinence | 10 |
| Hypermetabolism, defined as heart rate increase (> 25 percent above baseline) AND respiratory-rate increase (> 50 percent above baseline) | 5 |
| Negative workup for infectious, toxic, metabolic, or neurologic causes | 7 |
| Total: 100 | |
| No threshold score has been defined and validated for the investigators in making a diagnosis of NMS. | |
Differential diagnosis for neuroleptic malignant syndrome.
CSF: cerebrospinal fluid; CPK: creatine phosphokinase; MDMA: 3,4-methylenedioxymethamphetamine, commonly known as ecstasy; EEG: electroencephalogram; EMG: electromyogram
| Differential Diagnosis | Distinguishing Features |
| Infectious Meningitis or Encephalitis Brain Abscess Sepsis Rabies | History of prodromal viral illness, headaches or meningeal signs; Presence of seizures or localizing neurological signs; Brain imaging; CSF studies |
| Metabolic Acute Renal Failure Rhabdomyolysis Thyrotoxicosis Pheochromocytoma | Renal or thyroid function tests; Absence of neuroleptic treatment; Presence of severe hypertension; Significantly elevated catecholamines and metanephrines |
| Environmental Heat Stroke Spider Envenomations | History of exertion or exposure to high temperatures; Hot dry skin, skin lesion suggestive of spider bite; Absence of rigidity; Abrupt onset |
| Drug-Induced Malignant Hyperthermia Neuroleptic-induced Syndromes Parkinsonism Acute Dystonia Acute Akathisia Tardive Dyskinesia Postural Tremor Non-neuroleptic-induced Syndromes Serotonin Syndrome Anticholinergic Delirium Monamine Oxidase Inhibitor Toxicity Lithium Toxicity Salicylate Poisoning Strychnine Poisoning Drugs of Abuse (cocaine, amphetamine, methamphetamine, MDMA, phencyclidine) | History of use of inhalational anesthetics; Family history of malignant hyperthermia; Presence of hyperkinesias; Positive toxicology/drug-level screen; Low or normal CPK; Presence of nausea, vomiting, diarrhea; Presence of anticholinergic signs (dilated pupils, dry mouth, dry skin, urinary retention); Presence of rash, urticaria, or eosinophilia; History of drug dependence, abuse, or overdosages |
| Drug-withdrawal Syndrome Alcohol Benzodiazepines Baclofen Sedatives Hypnotics | History of drug dependence, abuse, or overdosages; Absence of neuroleptic treatment; Toxicology screen |
| Neurological or Psychiatric Disorder Parkinsonism Nonconvulsive Status Epilepticus Lethal Catatonia | Absence of fever or leukocytosis; Presence of hyperkinesias, later emergence of rigidity; Prior history of catatonic states; Absence of neuroleptic treatment EEG |
| Autoimmune Polymyositis | Proximal weakness; Abnormal EMG or muscle biopsy; Presence of cancer or interstitial lung disease |
Frequencies with which surveyed psychiatrists conducted physical examinations.
PE: physical examination; Senior: consultant, non-consultant career grade, professor, lecturer or research fellow, or senior trainee; Junior: psychiatric core trainee or General Practitioner (GP) or foundation trainee
* Data not reported
| N responded to an item | Senior | Junior | N (%) | |
| Routinely perform PE on inpatients | 2072 | 375/1324 | 294/340 | 682 (33.0) |
| How many PE on inpatients | 685 | * | * | * |
| 1-2 per week | 190 | 161 | 356 (58.6) | |
| 3-5 per week | 89 | 92 | 185 (30.4) | |
| 6-10 per week | 33 | 25 | 58 (9.5) | |
| 11-20 per week | 4 | 4 | 8 (1.3) | |
| More than 20 per week | 1 | 0 | 1 (0.2) | |
| Routinely perform PE on outpatients | 2066 | 165/1530 | 35/338 | 203 (9.8%) |
| How many PE on outpatients | 195 | * | * | * |
| 1-2 per week | 83 | 14 | 98 (59.4) | |
| 3-5 per week | 37 | 6 | 45 (27.3) | |
| 6-10 per week | 15 | 3 | 18 (10.9) | |
| 11-20 per week | 3 | 0 | 3 (1.8) | |
| More than 20 per week | 1 | 0 | 1 (0.6) |